ALISON POWELL: Open Payments
NPI 1295833176 · NORTH AUGUSTA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,778 in 100 payments from 21 companies in 2025. Trend: 2023 $1,978 · 2024 $1,952 · 2025 $1,778
Food & beverage: $1,778
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $291 |
| PFIZER INC. | 11 | $236 |
| AstraZeneca Pharmaceuticals LP | 13 | $225 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $164 |
| Novo Nordisk Inc | 9 | $156 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $115 |
| Otsuka America Pharmaceutical, Inc. | 4 | $99 |
| Lilly USA, LLC | 4 | $80 |
| Phathom Pharmaceuticals, Inc. | 5 | $80 |
| Exact Sciences Corporation | 3 | $57 |
Products named: ELIQUIS, TRINTELLIX, FARXIGA, CAPLYTA, REXULTI, Ozempic, UBRELVY, MOUNJARO.
Industry payments across SC — which companies pay providers there.
